Cargando…
Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer.
A number of randomized studies have been carried out in the UK and USA to determine the optimal radiotherapy dose schedule for advanced non-small-cell lung cancer (NSCLC). We have examined eight radiotherapy regimens from data taken from four randomized phase III studies carried out in the UK (1264...
Autores principales: | Singer, J. M., Price, P., Dale, R. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063234/ https://www.ncbi.nlm.nih.gov/pubmed/9862575 |
Ejemplares similares
-
Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020) -
Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022) -
Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer
por: Lu, Jia-Yang, et al.
Publicado: (2019) -
Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014) -
The Radiobiology of Human Cancer Radiotherapy
por: Hendry, J. H., et al.
Publicado: (1979)